Adapting and piloting a combination intervention to reduce heavy drinking and enhance HIV treatment and prevention outcomes among young men

Active Grant Awarded Last action

Award ID
R34AA032499
Recipient
Awarding agency
Obligated
$219,710

Award facts

Assistance listing
93.273 Alcohol Research Programs
Completion date 7% complete
Place of performance
La Jolla, CA 92093, USA

Award details come from USAspending.gov.

About this award

The National Institute on Alcohol Abuse and Alcoholism, within the National Institutes of Health and the Department of Health and Human Services, awarded Grant R34AA032499 to University of California, San Diego on September 9, 2026, obligating $219,710 under the Alcohol Research Programs (CFDA 93.273). The R34 study adapts and pilots KISOBOKA, a multilevel intervention originally developed in Uganda that combines motivational interviewing, behavioral economic strategies, and structural interventions to reduce high-risk alcohol use and improve HIV treatment and prevention outcomes among men. The adaptation targets an urban, upper-middle-income setting and uses a status-neutral approach to engage out-of-care men.

Aim 1 consults stakeholders through key informant interviews, selects adaptations through focus group discussions with young men, and theater tests the adapted materials with 20 eligible participants. Aim 2 implements the adapted intervention among 160 men with high-risk alcohol use who are either living with unsuppressed HIV or HIV-negative, at high risk for HIV acquisition, and not on PrEP or not adherent. Stratified randomization by HIV status balances participants between the intervention and screening and referral groups.

The period of performance runs from September 9, 2026 through August 31, 2029, with work performed at La Jolla, California 92093. The program supports research on biomedical, behavioral, and treatment factors for alcohol-related problems, and this award falls within that scope.

Description

Abstract
This R34 study seeks to adapt and pilot kisoboka, an effective multilevel intervention to reduce high-risk alcohol use and improve HIV treatment and prevention outcomes among men. High-risk alcohol use is a major driver of the global disease burden, slowing progress toward ending the HIV epidemic. High-risk alcohol use decreases engagement in care, adherence to antiretroviral therapy (art) and pre-exposure prophylaxis (PREP), with studies estimating that alcohol contributes up to 66% of new HIV infections among men. Across settings, men exhibit more high-risk drinking and lower healthcare engagement, resulting in poorer HIV outcomes and shorter life expectancy compared to women. Despite these risks, few alcohol services exist in low resource settings, and there is a GAP in science for evidence-based, effective alcohol-HIV interventions for men. Kisoboka, originally developed in uganda, combines motivational interviewing, behavioral economic strategies, and structural interventions to reduce high-risk alcohol use and improve HIV care outcomes. This study will adapt kisoboka to an urban, upper-middle-income setting with a status-neutral approach to engage out-of-care men, guided by a structured adaptation framework. (aim 1) first, we will consult with stakeholders through key informant interviews, decide on adaptations through focus group discussions with young men, and theater test the adapted materials with 20 eligible participants. (aim 2) the adapted intervention will be implemented among 160 men with high-risk alcohol use who are either (a) living with HIV and unsuppressed, or (B) HIV-negative and at high risk for HIV acquisition and not on PREP or not adherent. We will use stratified randomization by HIV status to ensure a balance between the intervention and screening and referral (S & R) groups. We will evaluate implementation outcomes among participants in the intervention group. Impact will be assessed by comparing change at 6 months from baseline in high-risk alcohol use and in viral suppression/PREP adherence between the intervention and S & R arms. Findings from this study will inform a larger trial and future efforts to scale up alcohol reduction strategies and improve HIV outcomes among men in diverse global settings.

Transactions

Action Obligated Date
Amendment $72,230
Original award $147,480

Quick answers

Who received award R34AA032499?

R34AA032499 was awarded to University Of California, San Diego by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 9, 2026.

How much is award R34AA032499 worth?

$219,710 has been obligated on R34AA032499.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award